Statement of Changes in Beneficial Ownership (4)

Date : 02/04/2019 @ 21h07
Source : Edgar (US Regulatory)
Valeur : Pfizer Inc (PFE)
Cours : 36.77  0.34 (0.93%) @ 02h00
Pfizer Cours Graphique
After Hours
Last Trade
Last $ 36,58 ▼ -0,19 (-0,52%)

Statement of Changes in Beneficial Ownership (4)

FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

MACKENZIE ALEXANDER R
2. Issuer Name and Ticker or Trading Symbol

PFIZER INC [ PFE ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Executive Vice President
(Last)          (First)          (Middle)

PFIZER INC.-CORP. SECRETARY, 235 EAST 42ND ST.
3. Date of Earliest Transaction (MM/DD/YYYY)

4/1/2019
(Street)

NEW YORK, NY 10017
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   4/1/2019     S    100.0000   (1) D $42.9300   124994.0000   D    
Common Stock   4/1/2019     S    100.0000   (1) D $42.7400   124894.0000   D    
Common Stock   4/1/2019     S    107.0000   (1) D $42.6100   124787.0000   D    
Common Stock   4/1/2019     S    128.0000   (1) D $42.6000   124659.0000   D    
Common Stock   4/1/2019     S    152.0000   (1) D $42.9200   124507.0000   D    
Common Stock   4/1/2019     S    200.0000   (1) D $42.5900   124307.0000   D    
Common Stock   4/1/2019     S    294.0000   (1) D $42.6700   124013.0000   D    
Common Stock   4/1/2019     S    300.0000   (1) D $42.7800   123713.0000   D    
Common Stock   4/1/2019     S    547.0000   (1) D $42.8600   123166.0000   D    
Common Stock   4/1/2019     S    555.0000   (1) D $42.8700   122611.0000   D    
Common Stock   4/1/2019     S    560.0000   (1) D $42.8900   122051.0000   D    
Common Stock   4/1/2019     S    600.0000   (1) D $42.7700   121451.0000   D    
Common Stock   4/1/2019     S    600.0000   (1) D $42.7600   120851.0000   D    
Common Stock   4/1/2019     S    623.0000   (1) D $42.9100   120228.0000   D    
Common Stock   4/1/2019     S    658.0000   (1) D $42.8300   119570.0000   D    
Common Stock   4/1/2019     S    703.0000   (1) D $42.8100   118867.0000   D    
Common Stock   4/1/2019     S    713.0000   (1) D $42.8400   118154.0000   D    
Common Stock   4/1/2019     S    800.0000   (1) D $42.7900   117354.0000   D    
Common Stock   4/1/2019     S    1100.0000   (1) D $42.8200   116254.0000   D    
Common Stock   4/1/2019     S    1134.0000   (1) D $42.8500   115120.0000   D    
Common Stock   4/1/2019     S    1230.0000   (1) D $42.8000   113890.0000   D    
Common Stock   4/1/2019     S    1581.0000   (1) D $42.9000   112309.0000   D    
Common Stock   4/1/2019     S    2215.0000   (1) D $42.8800   110094.0000   D    
Common Stock                  9336.0000   I   By Rule 16b-3 Plan  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
MACKENZIE ALEXANDER R
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK, NY 10017


Executive Vice President

Signatures
Susan E. Grant, by power of atty., for Alexander R. MacKenzie 4/2/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Pfizer (NYSE:PFE)
Graphique Historique de l'Action

1 an : De Oct 2018 à Oct 2019

Plus de graphiques de la Bourse Pfizer

Pfizer (NYSE:PFE)
Graphique Intraday de l'Action

Aujourd'hui : Jeudi 24 Octobre 2019

Plus de graphiques de la Bourse Pfizer
Dernières Valeurs Consultées
EU
GLE
Société Gé..
EU
ALU
ALCATEL-LU..
EU
PX1
CAC 40
ORA
Orange
FX
EURUSD
Euro vs Do..
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.


Inscrivez-vous maintenant pour créer votre liste d'actions personnalisée, en streaming.

Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20191024 04:52:01